AM(IST)on Thursday in an upbeat market. Mankind Pharma Ltd.(up 4.03 per cent), Gland Pharma Ltd.(up 1.78 per cent), Laurus ...

The Nifty Pharma index closed 0.26 per cent at 21752.00. Benchmark NSE Nifty50 index ended down 26.35 points at 23532.7, ...

Laurus Labs Ltd.(up 1.52 per cent), Glenmark Pharmaceuticals Ltd ... Mankind Pharma Ltd.(down 1.92 per cent), Sanofi India ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

AM(IST)on Friday in a weak market. Granules India Ltd.(up 1.74 per cent), Laurus Labs Ltd.(up 1.55 per cent), Glenmark ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: ...

Paul Hudson, CEO at Sanofi, said: “Sanofi’s purpose in chasing the miracles of science reaches far beyond our labs […] This capital commitment signals Sanofi’s accelerated ambitions in the ...

SSPC and NIBRT will use the lab to develop processes for advanced therapies ... Eli Lilly Janssen, MSD, Pfizer, and Sanofi on ...

Before that, she was CHRO at Oyster Point Pharma, Inc. Earlier, Ms. Sherman served in multiple roles of increasing responsibility at Sanofi, Schering-Plough ... Cabaletta Bio's headquarters and labs ...

Climate change and mosquitos are creating an epidemic of dengue in Oaxaca, as researchers work to counteract the disease.

Reliance Power, Nykaa, 3M India, Sula Vineyards, BASF India, Natco Pharma, and Rattanindia Enterprises are among other firms ...

Sanofi is conducting the two-part multicenter, randomized, open-label, controlled, parallel-group study (NCT04643002) to evaluate the safety, efficacy, pharmacokinetics and biomarker data of ...